Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common cause of dementia, typically showing progressive neurodegeneration in aging brains. The key signatures of the AD progression are the deposition of amyloid-beta (Aβ) peptides, the formation of tau tangles, and the induction of detrimental neuroinflammation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, You Jung, Diep, Yen N., Tran, Minh, Cho, Hansang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766709/
https://www.ncbi.nlm.nih.gov/pubmed/33339351
http://dx.doi.org/10.3390/ijms21249591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766709/
https://www.ncbi.nlm.nih.gov/pubmed/33339351
http://dx.doi.org/10.3390/ijms21249591

Ejemplares similares